• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌细胞系及其相应肿瘤的特征比较。

Comparison of features of human breast cancer cell lines and their corresponding tumors.

作者信息

Wistuba I I, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani A K, Kurvari V, Cunningham T H, Ashfaq R, Minna J D, Gazdar A F

机构信息

Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas 75235-8593, USA.

出版信息

Clin Cancer Res. 1998 Dec;4(12):2931-8.

PMID:9865903
Abstract

Although human tumor-derived cell lines play an important role in the investigation of cancer biology and genetics, there is no comprehensive study comparing tumor cell line properties with those of the individual tumors from which they were derived. We compared the properties of a series of 18 human breast cancer cell lines that were cultured for a median period of 25 months (range, 9-60 months) and their corresponding archival tumor tissues. We compared morphological characteristics, ploidy, and immunohistochemical expression of estrogen receptors, progesterone receptors, and HER2/neu and p53 proteins. For 17 of these cases, we also tested for allelic losses at 18 chromosomal regions frequently deleted in breast tumors using 51 polymorphic microsatellite markers, and we determined the TP53 gene mutation status in exons 5 to 10. There was an excellent correlation between the breast tumor cell lines and their corresponding tumor tissues for morphological features (100%); presence of aneuploidy (87%); immunohistochemical expression of estrogen receptors (87%), progesterone receptors (73%), and HER2/neu (93%) and p53 proteins (100%); allelic loss at all of the chromosomal regions analyzed (82-100% concordance); and TP53 gene mutations (75%). The same parental allele was lost in 279 (99%) of 281 of the comparisons of allelic losses. The fractional allelic loss indices (a reflection of the total allelic loss) of the cell lines and their corresponding tumor tissues were identical or similar in 15 (88%) of 17 paired comparisons. Although our previous studies (A. Gazdar et al., Int. J. Cancer, in press) indicated that only a subset of primary breast carcinomas that have several features indicative of advanced tumors with poor prognosis can be successfully cultured, the cell lines retain the properties of their parental tumors for lengthy culture periods and, thus, provide suitable model systems for biomedical studies.

摘要

尽管人肿瘤来源的细胞系在癌症生物学和遗传学研究中发挥着重要作用,但尚无全面研究将肿瘤细胞系的特性与其来源的个体肿瘤的特性进行比较。我们比较了一系列18个人类乳腺癌细胞系(培养中位时间为25个月,范围9 - 60个月)及其相应的存档肿瘤组织的特性。我们比较了形态学特征、倍性以及雌激素受体、孕激素受体、HER2/neu和p53蛋白的免疫组化表达。对于其中17例,我们还使用51个多态性微卫星标记检测了在乳腺肿瘤中经常缺失的18个染色体区域的等位基因缺失情况,并确定了外显子5至10中的TP53基因突变状态。乳腺肿瘤细胞系与其相应肿瘤组织在形态学特征(100%)、非整倍体的存在(87%)、雌激素受体(87%)、孕激素受体(73%)、HER2/neu(93%)和p53蛋白(100%)的免疫组化表达、所有分析染色体区域的等位基因缺失(一致性为82 - 100%)以及TP53基因突变(75%)方面存在极好的相关性。在281次等位基因缺失比较中的279次(99%)中,丢失的是相同的亲本等位基因。在17对配对比较中的15对(88%)中,细胞系及其相应肿瘤组织的部分等位基因缺失指数(反映总等位基因缺失情况)相同或相似。尽管我们之前的研究(A. Gazdar等人,《国际癌症杂志》,即将发表)表明,只有一部分具有多种提示预后不良的晚期肿瘤特征的原发性乳腺癌能够成功培养,但这些细胞系在长时间培养过程中保留了其亲本肿瘤的特性,因此为生物医学研究提供了合适的模型系统。

相似文献

1
Comparison of features of human breast cancer cell lines and their corresponding tumors.人乳腺癌细胞系及其相应肿瘤的特征比较。
Clin Cancer Res. 1998 Dec;4(12):2931-8.
2
Comparison of features of human lung cancer cell lines and their corresponding tumors.人肺癌细胞系及其相应肿瘤的特征比较。
Clin Cancer Res. 1999 May;5(5):991-1000.
3
Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.肿瘤组织学类型和分期而非p53、Her2-neu或组织蛋白酶D的表达是乳腺癌患者独立的预后因素。
Anticancer Res. 2004 May-Jun;24(3b):2061-8.
4
Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.通过多参数流式细胞术检测人乳腺癌中p53、Her-2/neu和ras过表达与非整倍体之间的相关性:浸润性导管癌中共同表型进化模式的证据
Clin Cancer Res. 2000 Jan;6(1):112-26.
5
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.环氧化酶-2在人乳腺癌及相邻导管原位癌中的表达
Cancer Res. 2002 Mar 15;62(6):1676-81.
6
Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.乳腺癌中bcl-2、细胞凋亡、P53和HER-2/neu的多变量分析:短期随访
Anticancer Res. 2002 Jul-Aug;22(4):2493-9.
7
Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.乳腺癌患者临床新鲜肿瘤样本中Bcl-2和Bax表达的免疫荧光测定研究
Anticancer Res. 2003 Jan-Feb;23(1B):565-8.
8
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.乳腺癌基底样亚型的临床病理意义:与激素受体及Her2/neu过表达表型的比较
Hum Pathol. 2006 Sep;37(9):1217-26. doi: 10.1016/j.humpath.2006.04.015. Epub 2006 Jul 18.
9
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.BRCA1 突变携带者的乳腺肿瘤免疫表型受诊断时年龄的影响。
Clin Cancer Res. 2001 Jul;7(7):1937-45.
10
Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.新型及先前描述的细胞膜标志物在人乳腺癌细胞系和肿瘤中的异常表达。
Clin Cancer Res. 2005 Jun 15;11(12):4357-64. doi: 10.1158/1078-0432.CCR-04-2107.

引用本文的文献

1
Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells?鼻咽癌细胞系:原发性鼻咽细胞的可靠替代品?
Cells. 2024 Mar 22;13(7):559. doi: 10.3390/cells13070559.
2
A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles.基于特征加权分子谱的泛癌症细胞系肿瘤相似性研究
Cell Rep Methods. 2021 Jun 21;1(2):100039. doi: 10.1016/j.crmeth.2021.100039.
3
Editor's inaugural issue foreword: perspectives on translational and clinical research.编辑创刊号前言:转化医学与临床研究视角
J Clin Transl Res. 2015 Jul 19;1(1):1-5. eCollection 2015 Jul 20.
4
Canine mammary tumors as a model for human disease.犬乳腺肿瘤作为人类疾病的模型。
Oncol Lett. 2018 Jun;15(6):8195-8205. doi: 10.3892/ol.2018.8411. Epub 2018 Apr 2.
5
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.乳腺癌细胞系分类及其与乳腺肿瘤亚型的相关性。
J Cancer. 2017 Sep 12;8(16):3131-3141. doi: 10.7150/jca.18457. eCollection 2017.
6
Cat Mammary Tumors: Genetic Models for the Human Counterpart.猫乳腺肿瘤:人类对应物的遗传模型
Vet Sci. 2016 Aug 16;3(3):17. doi: 10.3390/vetsci3030017.
7
Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.炭疽芽孢杆菌重组致死毒素对原发性乳腺导管癌细胞的抗增殖作用揭示了其治疗潜力。
Oncotarget. 2017 May 30;8(22):35835-35847. doi: 10.18632/oncotarget.16214.
8
Drug Sensitivity Assays of Human Cancer Organoid Cultures.人类癌症类器官培养物的药物敏感性测定
Methods Mol Biol. 2019;1576:339-351. doi: 10.1007/7651_2016_10.
9
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.AKT抑制剂MK-2206联合激素疗法用于雌激素受体阳性转移性乳腺癌绝经后女性的I期研究。
Clin Cancer Res. 2016 Jun 1;22(11):2650-8. doi: 10.1158/1078-0432.CCR-15-2160. Epub 2016 Jan 18.
10
Translating Treg Therapy in Humanized Mice.在人源化小鼠中翻译调节性T细胞疗法。
Front Immunol. 2015 Dec 14;6:623. doi: 10.3389/fimmu.2015.00623. eCollection 2015.